Filomena Morisco
Filomena Morisco
Professore Associato di Gastroenterologia, Università di Napoli Federico II
Email verificata su
Citata da
Citata da
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
Dietary antioxidant compounds and liver health
P Vitaglione, F Morisco, N Caporaso, V Fogliano
Critical reviews in food science and nutrition 44 (7-8), 575-586, 2005
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ...
Nature communications 6 (1), 8019, 2015
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins
P Vitaglione, F Morisco, G Mazzone, DC Amoruso, MT Ribecco, ...
Hepatology 52 (5), 1652-1661, 2010
F. 2005. Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo
G Graziani, G D’Argenio, C Tuccillo, C Loguercio, AM Ritieni
Gut 54, 193-200, 0
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects
C Loguercio, V De Girolamo, I de Sio, C Tuccillo, A Ascione, F Baldi, ...
Journal of hepatology 35 (5), 568-574, 2001
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ...
Journal of hepatology 62 (3), 617-624, 2015
Long-term outcome of interferon-α-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment
C Carella, G Mazziotti, F Morisco, G Manganella, M Rotondi, C Tuccillo, ...
The Journal of Clinical Endocrinology & Metabolism 86 (5), 1925-1929, 2001
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between …
BD Juran, GM Hirschfield, P Invernizzi, EJ Atkinson, Y Li, G Xie, R Kosoy, ...
Human molecular genetics 21 (23), 5209-5221, 2012
Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects
F Esposito, F Morisco, V Verde, A Ritieni, A Alezio, N Caporaso, ...
Alimentary pharmacology & therapeutics 17 (4), 595-601, 2003
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ...
Journal of Hepatology 61 (2), 333-341, 2014
Development and validation of a new prognostic system for patients with hepatocellular carcinoma
F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ...
PLoS Medicine 13 (4), e1002006, 2016
Serum insulin‐like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus‐related …
G Mazziotti, F Sorvillo, F Morisco, A Carbone, M Rotondi, G Stornaiuolo, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2002
Use of N, N-dimethyl-p-phenylenediamine to evaluate the oxidative status of human plasma
V Verde, V Fogliano, A Ritieni, G Maiani, F Morisco, N Caporaso
Free Radical Research 36 (8), 869-873, 2002
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but …
C Carella, G Mazziotti, F Morisco, M Rotondi, M Cioffi, C Tuccillo, ...
European journal of endocrinology 146 (6), 743-749, 2002
Patients with advanced hepatocellular carcinoma need a personalized management: a lesson from clinical practice
EG Giannini, L Bucci, F Garuti, M Brunacci, B Lenzi, M Valente, E Caturelli, ...
Hepatology 67 (5), 1784-1796, 2018
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver international 37 (4), 514-528, 2017
Sustained virological response: a milestone in the treatment of chronic hepatitis C
F Morisco, R Granata, T Stroffolini, M Guarino, L Donnarumma, L Gaeta, ...
World journal of gastroenterology: WJG 19 (18), 2793, 2013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20